By Robert L. LaFemina
Captures the country of the technology with twenty studies that research the newest in today’s antiviral drug discovery efforts.
- Presents the basic ideas of antiviral brokers and forecasts destiny possibilities.
- Investigates novel enzyme and protein inhibitors.
- Analyzes scientific points of viral an infection with reference to therapy and toxicity.
- Examines recognized and capability objectives in any respect phases of viral improvement.
- Serves as a source for virologists, biochemists, pharmaceutical chemists, and different investigators.
- Covers a extensive variety of viruses, together with HIV-1, HSV, and HCV.
Read or Download Antiviral research : strategies in antiviral drug discovery PDF
Similar viral books
This e-book has been created for sufferers who've made up our minds to make schooling and study an essential component of the remedy strategy. even though it additionally supplies details worthwhile to medical professionals, caregivers and different overall healthiness execs, it tells sufferers the place and the way to appear for info masking nearly all issues on the topic of filoviruses (also ebola virus; Ebola virus an infection; eco-friendly monkey virus illness; Marburg virus ), from the necessities to the main complex components of analysis.
Content material: Preface / Peter Gilbert -- results of environmental chemical substances and the host-pathogen dating: are there any detrimental results for human health and wellbeing? / Syed A. Sattar, Jason A. Tetro and V. Susan Springthorpe -- Disinfection and sterilization in healthcare amenities / Martin S. Favero -- Disinfection of prions / Kurt Giles .
An important instance of intravascular an infection is infective endocarditis (IE), a typical and severe illness in guy. long ago, those infections have been uniformly deadly, yet because the improvement of effective antimicrobial brokers, bac teriological healing has develop into functional and predictable. So, for some time, it appeared that intravascular an infection could reduce in significance and be relegated to the stockpile of health problems which physicians, one or generations prior, used to determine usually.
Through evaluating associations in Hawai'i and Louisiana designed to incarcerate people with a hugely stigmatized affliction, Colonizing Leprosy presents an leading edge learn of the advanced courting among U. S. imperialism and public well-being coverage within the overdue 19th and early 20th centuries.
- Antimicrobial Chemotherapy
- Bacterial Resistance to Antimicrobials
- Cases in Clinical Infectious Disease Practice
- Herpes Virus - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
Additional info for Antiviral research : strategies in antiviral drug discovery
Furman, J. A. Fyfe, P. de Miranda, L. Beauchamp, and H. J. Schaeffer. 1977. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. USA 74:5716–5720. 47. Ellis, M. , R. Waters, E. L. Hill, D. C. Lobe, D. W. Selleseth, and D. W. Barry. 1989. Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1. Antimicrob. Agents Chemother. 33:304–310. 48. , and B. Oberg. 1979. Characteristics of herpes virus mutants resistant to phosphonoformate and phosphonacetate.
Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system. Antimicrob. Agents Chemother. 38:2404–2408. 117. Nilsen, A. , T. Aasen, A. M. Halsos, B. R. Kinge, E. A. Tjotta, K. Wikstrom, and A. P. Fiddian. 1982. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet ii:571–573. 118. , and D. Faulds. 1998. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
Natl. Acad. Sci. USA 102:9667–9772. 65. , and D. M. Coen. 2003. High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant. J. Virol. 77:2282–2286. 66. , M. A. Link, C. L. Furness, and D. M. Coen. 2006. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase. J. Virol. 80:6568–6574. 67. Hall, J. , P. A. Furman, M. H. St. Clair, and C.